| 1 |
34774482 | Pathophysiological role of 27-hydroxycholesterol in human diseases. | 2022 Jan |
2 |
| 2 |
35326671 | 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer. | 2022 Mar 16 |
1 |
| 3 |
35629858 | Role of Lipoproteins in the Pathophysiology of Breast Cancer. | 2022 May 19 |
1 |
| 4 |
33368618 | 27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action. | 2021 Jan |
1 |
| 5 |
34556659 | High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer. | 2021 Sep 23 |
2 |
| 6 |
32075687 | Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort. | 2020 Feb 19 |
1 |
| 7 |
33176848 | CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients. | 2020 Nov 11 |
2 |
| 8 |
30016454 | Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort. | 2019 Apr 1 |
2 |
| 9 |
31001203 | The Roles of Cholesterol and Its Metabolites in Normal and Malignant Hematopoiesis. | 2019 |
2 |
| 10 |
29130512 | Hepatocyte-generated 27-hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha. | 2018 Mar |
5 |
| 11 |
29579190 | 27-Hydroxycholesterol Is an Estrogen Receptor β-Selective Negative Allosteric Modifier of 17β-Estradiol Binding. | 2018 May 1 |
2 |
| 12 |
26877254 | Mass spectrometric detection of 27-hydroxycholesterol in breast cancer exosomes. | 2017 May |
2 |
| 13 |
28442559 | Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. | 2017 Jul |
2 |
| 14 |
26872310 | Liver X receptor as a drug target for the treatment of breast cancer. | 2016 Jun |
1 |
| 15 |
27151575 | Going off the grid: ERα breast cancer beyond estradiol. | 2016 Jul |
2 |
| 16 |
26299212 | Breast cancer and (25R)-26-hydroxycholesterol. | 2015 Dec |
2 |
| 17 |
26610607 | Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. | 2015 Nov 27 |
1 |
| 18 |
25084324 | From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). | 2014 Nov |
2 |
| 19 |
23313336 | What are the physiological estrogens? | 2013 Mar |
2 |
| 20 |
24210818 | 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. | 2013 Nov 14 |
1 |
| 21 |
22932256 | Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy. | 2012 Sep 25 |
1 |
| 22 |
21420388 | Insights from the structure of estrogen receptor into the evolution of estrogens: implications for endocrine disruption. | 2011 Jul 1 |
2 |
| 23 |
21951066 | The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease. | 2011 Dec |
2 |
| 24 |
20501668 | The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. | 2010 Aug |
3 |
| 25 |
17872378 | 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. | 2008 Jan |
1 |
| 26 |
18722677 | 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. | 2008 Oct |
5 |